Top

Published in:

01-07-2020 | Letter to the Editor

Not all artifacts after magnetic guided sentinel lymph node biopsy are necessarily related to superparamagnetic iron oxide nanoparticles

Authors: Fredrik Wärnberg, Andreas Karakatsanis, Shahin Abdsaleh

Published in: Breast Cancer | Issue 4/2020

Excerpt

We read with interest the article by Vural et al. [1]. In their paper they refer to an own case report regarding imaging artefacts after supra paramagnetic nanoparticles of iron oxide (SPIO) [2]. In Uppsala, Sweden, we have used SPIO for sentinel node detection as our routine method since 2015 [3], often injected before tumour localisation with guidewire or MagSeed and the localisation is confirmed by a mammogram [4]. Interestingly, we have never encountered SPIO-related artifacts on follow-up mammograms, like those described by the authors. If mammography is done immediately after the injection of SPIO, fluid in the glandular tissue may be seen, but this is not SPIO specific. …

Vural V, Yılmaz OC. The Turkish SentiMAG feasibility trial: preliminary results. Breast Cancer. 2019. https://doi.org/10.1007/s12282-019-01016-8(epub ahead of print).CrossRefPubMed

Arslan G, Yılmaz C, Çelik L, Çubuk R, Tasalı N. Unexpected finding on mammography and MRI due to accumulation of iron oxide particles used for sentinel lymph node detection. Eur J Breast Health. 2019;15(3):200–2.CrossRef

Karakatsanis A, Daskalakis K, Stålberg P, Olofsson H, Andersson Y, Eriksson S, Bergkvist L, Wärnberg F. The routine use of Super Paramagnetic Iron Oxide nanoparticles as the sole method for Sentinel Node Biopsy in patients with breast cancer. The MONOS study. Br J Surg. 2017;104(12):1675–85.CrossRef

Hersi AF, Eriksson S, Ramos J, Abdsaleh S, Wärnberg F, Karakatsanis A. A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery. Eur J Surg Oncol. 2019;45(4):544–9.CrossRef

Title: Not all artifacts after magnetic guided sentinel lymph node biopsy are necessarily related to superparamagnetic iron oxide nanoparticles
Authors: Fredrik Wärnberg
Andreas Karakatsanis
Shahin Abdsaleh
Publication date: 01-07-2020
Publisher: Springer Japan
Published in: Breast Cancer / Issue 4/2020
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI: https://doi.org/10.1007/s12282-020-01070-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2020

Body size, silhouette trajectory and the risk of breast cancer in a Moroccan case–control study

miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1

Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer

The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways

Immediate one-stage implant-based breast reconstruction without the use of acellular dermal matrix in Japanese breast cancer patients

Behavior of Japanese women after being informed about the benefits and disadvantages of breast cancer screening: a questionnaire survey

Keynote webinar | Spotlight on antibody–drug conjugates in cancer